Sorrento Therapeutics, Inc.
(NASDAQ : SRNE)

( )
SRNE PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-0.50%93.831.3%$969.11m
BIIBBiogen Inc.
-0.56%225.901.3%$899.82m
AMGNAmgen Inc.
0.00%182.471.2%$419.94m
GILDGilead Sciences, Inc.
0.00%63.250.9%$414.24m
ILMNIllumina, Inc.
0.09%318.963.5%$277.70m
REGNRegeneron Pharmaceuticals, Inc.
-6.72%342.972.6%$242.59m
VRTXVertex Pharmaceuticals Incorporated
1.82%170.001.9%$224.08m
ONCESpark Therapeutics, Inc.
-0.13%110.7111.2%$169.77m
ALXNAlexion Pharmaceuticals, Inc.
0.31%126.302.0%$165.86m
EXASExact Sciences Corporation
-3.57%91.8125.3%$151.11m
SRPTSarepta Therapeutics, Inc.
-2.35%118.7314.7%$141.38m
AAgilent Technologies, Inc.
-0.04%75.431.6%$120.09m
INCYIncyte Corporation
-3.46%74.322.5%$91.96m
IONSIonis Pharmaceuticals, Inc.
0.14%72.778.3%$88.48m
BMRNBioMarin Pharmaceutical Inc.
0.00%82.354.3%$84.63m

Company Profile

Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.